{"id":"https://openalex.org/W4388411522","doi":"https://doi.org/10.1158/2767-9764.24512236.v1","title":"FIGURE 5 from PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies","display_name":"FIGURE 5 from PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies","publication_year":2023,"publication_date":"2023-11-06","ids":{"openalex":"https://openalex.org/W4388411522","doi":"https://doi.org/10.1158/2767-9764.24512236.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.24512236.v1","doi":"https://doi.org/10.1158/2767-9764.24512236.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.24512236.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.24512236.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052263916","display_name":"Jack Carter","orcid":"https://orcid.org/0000-0002-7784-7897","observed_orcids":["https://orcid.org/0000-0002-7784-7897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jack Carter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7784-7897","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091867223","display_name":"Michael Hulse","orcid":"https://orcid.org/0000-0002-6691-365X","observed_orcids":["https://orcid.org/0000-0002-6691-365X","https://orcid.org/0009-0000-7928-1842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Hulse","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6691-365X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017032244","display_name":"Monisha Sivakumar","orcid":"https://orcid.org/0009-0002-8937-4289","observed_orcids":["https://orcid.org/0009-0002-8937-4289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monisha Sivakumar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-8937-4289","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030876681","display_name":"Jessica Burtell","orcid":"https://orcid.org/0000-0002-7763-6379","observed_orcids":["https://orcid.org/0000-0002-7763-6379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Burtell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7763-6379","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062031656","display_name":"Venkat Thodima","orcid":"https://orcid.org/0000-0002-0939-3707","observed_orcids":["https://orcid.org/0000-0002-0939-3707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Venkat Thodima","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0939-3707","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064147672","display_name":"Min Wang","orcid":"https://orcid.org/0009-0004-9364-1284","observed_orcids":["https://orcid.org/0009-0004-9364-1284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-9364-1284","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034853468","display_name":"Anjana Agarwal","orcid":"https://orcid.org/0009-0008-7625-1240","observed_orcids":["https://orcid.org/0009-0008-7625-1240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anjana Agarwal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-7625-1240","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049083963","display_name":"Komali Vykuntam","orcid":"https://orcid.org/0009-0004-4538-4535","observed_orcids":["https://orcid.org/0009-0004-4538-4535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Komali Vykuntam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-4538-4535","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086821262","display_name":"Jacob Spruance","orcid":"https://orcid.org/0000-0003-2744-8123","observed_orcids":["https://orcid.org/0000-0003-2744-8123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacob Spruance","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2744-8123","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435781","display_name":"Neha Bhagwat","orcid":"https://orcid.org/0009-0002-5766-0272","observed_orcids":["https://orcid.org/0009-0002-5766-0272"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neha Bhagwat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-5766-0272","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004443645","display_name":"Joseph D. Rager","orcid":"https://orcid.org/0009-0004-6008-9630","observed_orcids":["https://orcid.org/0009-0004-6008-9630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Rager","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-6008-9630","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036665836","display_name":"Bruce Ruggeri","orcid":"https://orcid.org/0009-0002-0095-873X","observed_orcids":["https://orcid.org/0009-0002-0095-873X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Ruggeri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-0095-873X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018193992","display_name":"Peggy Scherle","orcid":"https://orcid.org/0000-0003-0783-6815","observed_orcids":["https://orcid.org/0000-0003-0783-6815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peggy Scherle","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0783-6815","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5023093205","display_name":"Koichi Ito","orcid":"https://orcid.org/0000-0003-1421-3122","observed_orcids":["https://orcid.org/0000-0003-1421-3122"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koichi Ito","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1421-3122","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13157","display_name":"Cancer-related gene regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prmt5-inhibitors","display_name":"PRMT5 inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.8669999837875366},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.9739999771118164},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.734000027179718},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.8690000176429749},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.8429999947547913},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6499999761581421},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.919482946395874},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.6598036289215088},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6531957983970642},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.46709293127059937},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4360000193119049},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41422832012176514},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39798504114151},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36832451820373535},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3372235894203186},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3208822011947632},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25490903854370117},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.2467254400253296},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0726730227470398},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06017810106277466},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.051663726568222046},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.24512236.v1","doi":"https://doi.org/10.1158/2767-9764.24512236.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.24512236.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.24512236.v1","doi":"https://doi.org/10.1158/2767-9764.24512236.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.24512236.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388422966","https://openalex.org/W4388424081","https://openalex.org/W4388424187","https://openalex.org/W4388423210","https://openalex.org/W4387799386","https://openalex.org/W4388422886","https://openalex.org/W4385979967","https://openalex.org/W6902258623","https://openalex.org/W4388411538","https://openalex.org/W4388423425"],"abstract_inverted_index":{"PRT543":[0,40,82,107],"inhibits":[1],"growth":[2],"of":[3,18,49],"PARP":[4],"inhibitor\u2013resistant":[5],"ovarian":[6,51,68],"and":[7,13,22],"breast":[8,92],"cancer":[9,52,69,93],"models":[10],"in":[11,14,59],"vitro":[12],"vivo.":[15],"Cell":[16],"proliferation":[17],"UWB1.289":[19],"parental,":[20],"BRCA1-overexpressing,":[21],"olaparib-resistant":[23],"cell":[24],"lines":[25],"was":[26,79,104],"assessed":[27],"by":[28],"cell-titer":[29],"glo":[30],"assays":[31],"following":[32],"10":[33,87,112],"days":[34],"treatment":[35],"with":[36,55,74,81,99,106],"olaparib":[37,78,84,103,109],"(A)":[38],"or":[39,58,83,108],"(B;":[41],"n":[42],"=":[43,62,86,111],"3).":[44],"C,In":[45],"vivo":[46,66,90],"mouse":[47,67,91],"CDX":[48],"A2780":[50],"cells":[53],"treated":[54,80,105],"PRT543,":[56],"olaparib,":[57],"combination":[60],"(n":[61,85,110],"8":[63],"mice/group).":[64,88,113],"D,In":[65],"PDX":[70,94],"(CTG-1086,":[71],"BRCA1":[72],"deletion)":[73,98],"acquired":[75,100],"resistance":[76,101],"to":[77,102],"E,In":[89],"(CTG-089,":[95],"BRCA1/2":[96],"hemizygous":[97],"A\u2013E,":[114],"Data":[115],"are":[116],"represented":[117],"as":[118],"mean":[119],"\u00b1":[120],"SEM.":[121],"C\u2013E,":[122],"Asterisks":[123],"indicate":[124],"statistical":[125],"significance":[126],"from":[127],"vehicle":[128],"(**,":[129],"P":[130],"<0.01)":[131],"using":[132],"a":[133],"Dunnett":[134],"test.":[135]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2023-11-07T00:00:00"}